BeiGene Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:49BA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Apr 24	Sell€6,979,430	John Oyler	Individual	50,000	€143.98
29 Feb 24	Sell€61,363	Julia Wang	Individual	397	€154.57
26 Jan 24	Buy€21,813,392	Capital Research and Management Company	Company	146,849.93	€148.54
14 Nov 23	Sell€182,943,970	Baker Bros. Advisors LP	Company	1,100,000	€166.31
02 Aug 23	Buy€498,239	Capital Research and Management Company	Company	33,854.3	€14.72
31 Jul 23	Sell€155,219	Chan Lee	Individual	791	€196.23
03 Jul 23	Sell€77,662	Julia Wang	Individual	472	€164.54
26 Jun 23	Sell€249,843	Xiaobin Wu	Individual	1,495	€167.12
26 Jun 23	Sell€184,716	Wang Lai	Individual	1,108	€167.84
23 Jun 23	Sell€141,138	Julia Wang	Individual	840	€168.02
20 Jun 23	Sell€233,769	Wang Lai	Individual	1,325	€176.43
20 Jun 23	Sell€33,543	Julia Wang	Individual	190	€176.54
20 Jun 23	Sell€309,322	Xiaobin Wu	Individual	1,753	€176.45
14 Jun 23	Sell€13,189,888	Hillhouse Investment Management, Ltd.	Company	68,056	€194.87
12 Jun 23	Sell€38,095,046	Hillhouse Investment Management, Ltd.	Company	189,353	€202.87
07 Jun 23	Sell€690,860	Xiaobin Wu	Individual	3,291	€211.25
07 Jun 23	Sell€96,986	Wang Lai	Individual	462	€211.25
08 May 23	Sell€1,611,931	Xiaobin Wu	Individual	7,000	€230.28

Insider Buying: 49BA insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 76.01% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.1%	Amgen Inc.	18,938,119	€2.7b	0%	no data
10.5%	Hillhouse Investment Management, Ltd.	10,989,658	€1.6b	0%	9.97%
10.1%	Baker Bros. Advisors LP	10,576,080	€1.5b	-9.42%	20.12%
8.1%	Capital Research and Management Company	8,461,727	€1.2b	11.3%	0.07%
4.77%	PRIMECAP Management Company	4,988,639	€716.2m	-0.4%	0.55%
3.92%	Baillie Gifford & Co.	4,091,228	€587.4m	-0.08%	0.27%
3.45%	John Oyler	3,601,461	€517.0m	-2.7%	no data
2.88%	Temasek Holdings (Private) Limited	3,014,171	€432.7m	0%	0.46%
2.65%	BlackRock, Inc.	2,769,915	€397.7m	2.14%	0.01%
1.88%	The Vanguard Group, Inc.	1,968,814	€282.7m	0.51%	0.01%
1.83%	T. Rowe Price Group, Inc.	1,908,427	€274.0m	9.07%	0.03%
1.64%	FMR LLC	1,708,519	€245.3m	-27.1%	0.02%
1.1%	China Asset Management Co. Ltd.	1,149,065	€165.0m	-0.47%	0.26%
0.77%	Xiaodong Wang	805,732	€115.7m	0%	no data
0.66%	Bosera Asset Management Co., Ltd.	687,273	€98.7m	0%	0.6%
0.48%	Tavistock Life Sciences	500,000	€71.8m	0%	4.49%
0.44%	Invesco Ltd.	458,434	€65.8m	-68.8%	0.02%
0.39%	Artal Group S.A.	404,480	€58.1m	0.14%	1.8%
0.37%	Goldman Sachs Group, Investment Banking and Securities Investments	385,714	€55.4m	53.7%	0.04%
0.35%	Guangzhou Development District Holding Group Limited	368,385	€52.9m	0%	no data
0.35%	SDIC Unity Capital Co., Ltd.	368,385	€52.9m	0%	5.69%
0.34%	Public Investment Fund	354,385	€50.9m	0%	0.02%
0.33%	Wanjia Asset Management Co., Ltd.	346,050	€49.7m	0%	1.09%
0.29%	GF Fund Management Co., Ltd.	302,610	€43.4m	0%	0.14%
0.26%	Penghua Fund Management Co., Ltd.	270,823	€38.9m	6.97%	0.38%